<ENAMEX TYPE="ORGANIZATION">BRISTOL-MYERS Co.</ENAMEX> (<ENAMEX TYPE="LOCATION">New York</ENAMEX>) -- <ENAMEX TYPE="PERSON">Stephen Keith Carter</ENAMEX> was named president of the pharmaceutical research and development division of this health-care products firm. He had been senior vice president of pharmaceutical and medical development in the division. <ENAMEX TYPE="PERSON">Jerome Birnbaum</ENAMEX> was named to the newly created post of executive vice president of research in the division. Mr. <ENAMEX TYPE="PERSON">Carter</ENAMEX> succeeds <ENAMEX TYPE="PERSON">Giulio Vita</ENAMEX>, who remains a vice president of the corporation and takes the newly created post of senior vice president and scientific adviser to the <ENAMEX TYPE="ORGANIZATION">Science & Technology Group</ENAMEX>.
